The Healthcare News Diaries
The Healthcare News Diaries
Blog Article
Novo CEO pressed by Senate to cut selling prices of obesity, diabetes prescription drugs CEO Lars Fruergaard Jørgensen instructed lawmakers the business would contemplate new talks with insurers regarding the record rates of Wegovy and copyright should they pledge to keep the medicines on their formularies.
Since some electronic overall health startups funded all through the height of the financial investment growth have been working for quite a few a long time, the field could see data on how efficient these methods are at increasing accessibility and top quality of care, said Cheryl Cheng, founder of venture capital firm Vive Collective.
Why Cigna is capping Price tag will increase for expensive GLP-1 weight reduction medication The move — the first of its form — will come as pharmacy advantage managers carry on to test to establish their price to shoppers, and reveals how big players are shoring up to fulfill sky-high GLP-1 demand.
The HHS has also signaled curiosity in boosting cybersecurity demands for hospitals by Medicare and Medicaid, releasing an idea paper in December that outlined a technique to receive new authority and funding.
Blue Protect of California sidesteps PBMs with new Humira biosimilar offer It’s the first time this sort of product is accustomed to convey a Humira biosimilar to marketplace, based on the insurance provider — and it yields a Significantly decrease Price tag than each the model-identify Variation from the drug and its biologic copycats.
Nonetheless, desire in emerging technologies is superior this yr — particularly as synthetic intelligence guarantees to streamline functions and lessen administrative burdens for clinicians.
‘As rapid as is possible but no more quickly than is safe’: Hospitals, tech businesses confront AI governance Regulators seeking to erect guardrails around AI are going through a Sisyphean job, industry experts said at HIMSS. How will you oversee something which is consistently altering?
“We don't desire this sale to blow up Until it Completely has got to,” Rate said. “But the things they’re becoming asked to perform is simply a bridge too far.”
“This is where you'll see a little bit of that separation between the wheat plus the chaff concerning the businesses that have built definitely robust medical types with very good unit economics and will scale, as opposed to the ones that maybe were being even now drafting off of COVID pandemic tailwinds,” she mentioned.
In Washington, federal regulators may possibly form the phase for the industry after antitrust agencies revised merger recommendations last year that may chill dealmaking.
An write-up from Top healthcare tendencies in 2024 Here’s what marketplace experts see coming down the pike for hospitals, insurers and electronic health firms this year.
The fourth component discusses designs to market facts sharing, boost broadband infrastructure and supply direction on cybersecurity. The former wellbeing IT prepare, released in Oct 2020, drove “important development” across The federal government and personal sector to accelerate access, exchange and utilization of electronic well being information and facts, based on the agency. The new system aims to build on that get the job done, aiming to modernize public health infrastructure once the COVID-19 pandemic, deal with health disparities and deal with the speedily evolving use of AI in healthcare. While tech giants are promising AI instruments that lessen vendors’ administrative jobs, some professionals are anxious there isn’t ample oversight in to the immediately establishing products.
CMS holds accountable treatment businesses harmless for ‘very suspect’ Medicare billing Aberrant billing for urinary catheters last calendar year could have produced it more challenging for ACOs in Medicare to usher in shared financial savings. That’s now not the situation under a completely new last rule.
FTC sues significant pharmacy benefit supervisors more than insulin costs The click here company brought motion towards Caremark, Convey Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating tactics “artificially inflated” the checklist cost of existence-preserving insulin medicine.